Venus Concept is a medical technology company that sells energy-based aesthetic devices and robotic hair restoration systems to physicians and aesthetic clinics. Its core aesthetic line uses proprietary (MP)² technology, combining multipolar radiofrequency energy with pulsed electromagnetic field therapy to treat skin tightening, wrinkle reduction, body contouring, and fat reduction. Key aesthetic platforms include Venus Legacy, Venus Versa, Venus Bliss, Venus Viva, and Venus Velocity. A key selling point is that these systems are designed to be operated by non-physician staff under physician supervision, making them accessible to general practitioners and medical spas — Venus Concept's fastest-growing customer segment. In hair restoration, Venus Concept sells the ARTAS iX, an AI-driven robotic follicular unit extraction system targeting high-volume hair restoration surgeons, and NeoGraft, a lower-cost semi-automated device for lower-volume practices. Venus Concept generates revenue from system sales, an internal financing program (Venus Prime), consumables, and service contracts. A core strategic priority is shifting away from internal financing toward outright cash sales, which improves cash flow quality. Venus Concept sells directly in 12 international markets and through distributors in over 40 additional countries, with North America as the primary direct market. The company is not profitable, carries an accumulated deficit of approximately $309M, and is actively pursuing strategic alternatives while depending on continued support from its primary lender, Madryn Asset Management.